125 related articles for article (PubMed ID: 8205544)
1. An antibody which specifically recognizes prelamin A but not mature lamin A: application to detection of blocks in farnesylation-dependent protein processing.
Sinensky M; Fantle K; Dalton M
Cancer Res; 1994 Jun; 54(12):3229-32. PubMed ID: 8205544
[TBL] [Abstract][Full Text] [Related]
2. The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localization.
Dalton MB; Fantle KS; Bechtold HA; DeMaio L; Evans RM; Krystosek A; Sinensky M
Cancer Res; 1995 Aug; 55(15):3295-304. PubMed ID: 7614464
[TBL] [Abstract][Full Text] [Related]
3. Nucleoplasmic localization of prelamin A: implications for prenylation-dependent lamin A assembly into the nuclear lamina.
Lutz RJ; Trujillo MA; Denham KS; Wenger L; Sinensky M
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3000-4. PubMed ID: 1557405
[TBL] [Abstract][Full Text] [Related]
4. The processing pathway of prelamin A.
Sinensky M; Fantle K; Trujillo M; McLain T; Kupfer A; Dalton M
J Cell Sci; 1994 Jan; 107 ( Pt 1)():61-7. PubMed ID: 8175923
[TBL] [Abstract][Full Text] [Related]
5. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence.
Caron M; Auclair M; Donadille B; Béréziat V; Guerci B; Laville M; Narbonne H; Bodemer C; Lascols O; Capeau J; Vigouroux C
Cell Death Differ; 2007 Oct; 14(10):1759-67. PubMed ID: 17612587
[TBL] [Abstract][Full Text] [Related]
6. Drugs affecting prelamin A processing: effects on heterochromatin organization.
Mattioli E; Columbaro M; Capanni C; Santi S; Maraldi NM; D'Apice MR; Novelli G; Riccio M; Squarzoni S; Foisner R; Lattanzi G
Exp Cell Res; 2008 Feb; 314(3):453-62. PubMed ID: 18093584
[TBL] [Abstract][Full Text] [Related]
7. Isoprenylation is required for the processing of the lamin A precursor.
Beck LA; Hosick TJ; Sinensky M
J Cell Biol; 1990 May; 110(5):1489-99. PubMed ID: 2335559
[TBL] [Abstract][Full Text] [Related]
8. Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors.
Rusiñol AE; Sinensky MS
J Cell Sci; 2006 Aug; 119(Pt 16):3265-72. PubMed ID: 16899817
[TBL] [Abstract][Full Text] [Related]
9. RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: implications for Hutchinson-Gilford progeria syndrome.
Gruber J; Lampe T; Osborn M; Weber K
J Cell Sci; 2005 Feb; 118(Pt 4):689-96. PubMed ID: 15671064
[TBL] [Abstract][Full Text] [Related]
10. Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24.
Corrigan DP; Kuszczak D; Rusinol AE; Thewke DP; Hrycyna CA; Michaelis S; Sinensky MS
Biochem J; 2005 Apr; 387(Pt 1):129-38. PubMed ID: 15479156
[TBL] [Abstract][Full Text] [Related]
11. Investigating the purpose of prelamin A processing.
Davies BS; Coffinier C; Yang SH; Barnes RH; Jung HJ; Young SG; Fong LG
Nucleus; 2011; 2(1):4-9. PubMed ID: 21647293
[TBL] [Abstract][Full Text] [Related]
12. Effects of prelamin A processing inhibitors on the differentiation and activity of human osteoclasts.
Zini N; Avnet S; Ghisu S; Maraldi NM; Squarzoni S; Baldini N; Lattanzi G
J Cell Biochem; 2008 Sep; 105(1):34-40. PubMed ID: 18442054
[TBL] [Abstract][Full Text] [Related]
13. Lco1 is a novel widely expressed lamin-binding protein in the nuclear interior.
Vlcek S; Foisner R; Wilson KL
Exp Cell Res; 2004 Aug; 298(2):499-511. PubMed ID: 15265697
[TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of prelamin A in early Xenopus embryos induces apoptosis.
Peter A; Stick R
Eur J Cell Biol; 2008 Nov; 87(11):879-91. PubMed ID: 18675490
[TBL] [Abstract][Full Text] [Related]
15. Subcellular localization and partial purification of prelamin A endoprotease: an enzyme which catalyzes the conversion of farnesylated prelamin A to mature lamin A.
Kilic F; Johnson DA; Sinensky M
FEBS Lett; 1999 Apr; 450(1-2):61-5. PubMed ID: 10350058
[TBL] [Abstract][Full Text] [Related]
16. N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.
Bifulco M; D'Alessandro A; Paladino S; Malfitano AM; Notarnicola M; Caruso MG; Laezza C
FEBS J; 2013 Dec; 280(23):6223-32. PubMed ID: 24112551
[TBL] [Abstract][Full Text] [Related]
17. Expression of prelamin A but not mature lamin A confers sensitivity of DNA biosynthesis to lovastatin on F9 teratocarcinoma cells.
Sinensky M; McLain T; Fantle K
J Cell Sci; 1994 Aug; 107 ( Pt 8)():2215-8. PubMed ID: 7983180
[TBL] [Abstract][Full Text] [Related]
18. Prelamin A is involved in early steps of muscle differentiation.
Capanni C; Del Coco R; Squarzoni S; Columbaro M; Mattioli E; Camozzi D; Rocchi A; Scotlandi K; Maraldi N; Foisner R; Lattanzi G
Exp Cell Res; 2008 Dec; 314(20):3628-37. PubMed ID: 18951892
[TBL] [Abstract][Full Text] [Related]
19. The truncated prelamin A in Hutchinson-Gilford progeria syndrome alters segregation of A-type and B-type lamin homopolymers.
Delbarre E; Tramier M; Coppey-Moisan M; Gaillard C; Courvalin JC; Buendia B
Hum Mol Genet; 2006 Apr; 15(7):1113-22. PubMed ID: 16481358
[TBL] [Abstract][Full Text] [Related]
20. In vitro assay and characterization of the farnesylation-dependent prelamin A endoprotease.
Kilic F; Dalton MB; Burrell SK; Mayer JP; Patterson SD; Sinensky M
J Biol Chem; 1997 Feb; 272(8):5298-304. PubMed ID: 9030603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
